ORIGINAL RESEARCH
Accepted on 06 Mar 2025
Telitacicept as an Alternative to Non-Steroidal Immunosuppressive Therapies in the Treatment of Myasthenia Gravis: A Study on Clinical Efficacy and Steroid-Sparing Effect
doi 10.3389/fimmu.2025.1549034
- Frontiers in Neurology
- Neurological Biomarkers
- Research Topics
- Autoantibodies and autoimmune neuromuscular disorders
Autoantibodies and autoimmune neuromuscular disorders
1,404
Total downloads
5,141
Total views and downloads
Articles
CORRECTION
Published on 12 Feb 2025
Corrigendum: Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2025.1567315
- 201 views
ORIGINAL RESEARCH
Published on 06 Jan 2025
Applicability of a serodiagnostic line blot for idiopathic inflammatory myopathy: the muscle biopsy is not all
doi 10.3389/fneur.2024.1504260
- 725 views
CASE REPORT
Published on 07 Oct 2024
Case report: target antigen and subclass switch in a patient with autoimmune nodopathy
doi 10.3389/fimmu.2024.1475478
- 835 views
ORIGINAL RESEARCH
Published on 13 Sep 2024
Exhausted signature and regulatory network of NK cells in myasthenia gravis
doi 10.3389/fimmu.2024.1397916
- 1,397 views
- 1 citation
Published in
Frontiers in Neurology
Neurological Biomarkers
Participating Journals
Frontiers in Immunology
- 5.7 impact factor
- 9.8 citescore